Serial #79391771
LIVE

Serial Number

79391771

Owner

BioInvent International AB

Attorney

Brett A. Manchel

Filing Date

Jan 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79391771 Trademark

Serial Number: 79391771 • Registration: 7504895

Serial #79391771 is a trademark filed by BioInvent International AB on January 11, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BioInvent International AB (7 trademarks)

Solvegatan 41
S-223 70 Lund , SE

Entity Type: 03

Trademark Details

Filing Date

January 11, 2024

Registration Date

September 17, 2024

Published for Opposition

July 2, 2024

Goods & Services

Chemicals for use in industry and science; biological preparations for use in industry and science; chemical preparations for analytical and diagnostic purposes and laboratory use, namely, chemical preparations for analytical scientific purposes, chemical diagnostic reagents for scientific use, and chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for use in protein analysis, other than for medical or veterinary purposes; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical products for biotechnological purposes, namely, chemicals for use in biotechnological product development; chemical products for immunoassay, namely, immunoassay reagents for non-medical purposes; antibody reagents for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use.

Scientific research and development; pharmaceutical product development; consultancy pertaining to pharmacology; research and development services in the field of antibody technology

Chemicals for medical purposes, namely, chemical reagents for medical purposes; chemicals for analytical purposes, namely, chemical reagents for medical use; biological preparations for use in cell cultures for medical purposes; antibodies for medical purposes; pharmaceuticals, namely, pharmaceutical preparations for treatment of autoimmune, inflammatory, cardiovascular, infectious, viral, cardiopulmonary, renal, gastrointestinal, respiratory, dermatological, oncological, heptalogical, neurological, musculoskeletal, bacterial, and metabolic diseases and disorders, and pharmaceutical preparations for treatment of cancer

Custom manufacturing of antibodies for third parties; custom manufacture of pharmaceuticals

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 5, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 20, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 20, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 8, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 13, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 29, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2024 TROA
REFUSAL PROCESSED BY IB
May 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 26, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 21, 2024 REPR